Cancer Stem Cells: Advances in Biology and Clinical Translation | EK46

May 19, 2021 ‐ May 21, 2021



Sessions

Targeting cancer stem cells with differentiation agents as an alternative to genotoxic chemotherapy for the treatment of malignant testicular germ cell tumors

May 19, 2021 12:00am ‐ May 19, 2021 12:00am

Speaker(s):

The role of lncRNA ADAMTS9-AS2 in cancer: a double-edged sword in metastatic progression?

May 19, 2021 12:00am ‐ May 19, 2021 12:00am

Speaker(s):

Targeting HNF1A-dependent stemness and tumor growth in pancreatic cancer

May 19, 2021 12:00am ‐ May 19, 2021 12:00am

Speaker(s):
  • Bharani Muppavarapu, MSc, Roswell Park Comprehensive Cancer Center division, University at Buffalo

ALDH proteins as regulators of prostate cancer metastases and radioresistance

May 19, 2021 12:00am ‐ May 19, 2021 12:00am

Speaker(s):

Single-cell atlas of tumor clonal evolution in liver cancer

May 19, 2021 12:00am ‐ May 19, 2021 12:00am

Speaker(s):

RNA binding protein DDX5 directs DCLK+ tumor stem cell specification to regulate microbial repertoire and promote tumorigenesis in the intestine

May 19, 2021 12:00am ‐ May 19, 2021 12:00am

Speaker(s):

C/EBPB-dependent Adaptation to Palmitic Acid Promotes Stemness in Hormone Receptor Negative Breast Cancer

May 19, 2021 12:00am ‐ May 19, 2021 12:00am

Speaker(s):

Welcoming Remarks iconWelcoming Remarks

Preview Available

Welcoming Remarks

May 19, 2021 8:00am ‐ May 19, 2021 8:10am

Speaker(s):

Stem Cells and Cancer iconStem Cells and Cancer

Preview Available

Stem Cells and Cancer

May 19, 2021 8:00am ‐ May 19, 2021 9:55am

Co-Chair(s):

Chemical Induction of Pluripotency

May 19, 2021 8:10am ‐ May 19, 2021 8:35am

Speaker(s):
  • Duanqing Pei, PhD, Guangzhou Institutes of Biomedicine and Health